Foss Olav A, Mjønes Patricia, Fismen Silje, Christensen Eidi
Orthopaedic Research Centre, Clinic of Orthopaedy, Rheumatology and Dermatology, St. Olavs Hospital, Trondheim University Hospital, Trondheim 7030, Norway.
Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim 7030, Norway; Department of Pathology and Medical Genetics, St. Olavs Hospital, Trondheim University Hospital, Trondheim 7030, Norway.
J Skin Cancer. 2016;2016:6146091. doi: 10.1155/2016/6146091. Epub 2016 Jan 28.
Basal cell carcinoma (BCC) is an invasive epithelial skin tumour. The thickness of the outermost epidermal layer of the skin, the stratum corneum (SC), influences drug uptake and penetration into tumour and may thereby affect the response of BCC to topical treatment. The aim was to investigate a possible relationship between the thickness of the SC and that of the viable part of BCC. Histopathological evaluations of the corresponding SC and viable tumour thickness measurements of individual BCCs of different subtypes were explored. A total of 53 BCCs from 46 patients were studied. The median tumour thickness was 1.7 mm (0.8-3.0 mm), with a significant difference between subtypes (p < 0.001). The SC had a median thickness of 0.3 mm (0.2-0.4 mm), with no difference between tumour subtypes (p = 0.415). Additionally, no significant association between the thickness of the SC and that of the viable part of the tumour was demonstrated (p = 0.381). In conclusion our results indicate that SC thickness is relatively constant in BCC.
基底细胞癌(BCC)是一种侵袭性上皮性皮肤肿瘤。皮肤最外层表皮层即角质层(SC)的厚度会影响药物摄取以及向肿瘤内的渗透,进而可能影响BCC对局部治疗的反应。目的是研究SC厚度与BCC存活部分厚度之间的可能关系。对不同亚型的单个BCC的相应SC和存活肿瘤厚度测量值进行了组织病理学评估。共研究了来自46例患者的53个BCC。肿瘤厚度中位数为1.7毫米(0.8 - 3.0毫米),各亚型之间存在显著差异(p < 0.001)。SC厚度中位数为0.3毫米(0.2 - 0.4毫米),肿瘤亚型之间无差异(p = 0.415)。此外,未显示出SC厚度与肿瘤存活部分厚度之间存在显著关联(p = 0.381)。总之,我们的结果表明,BCC中的SC厚度相对恒定。